Neoadjuvant and Adjuvant Checkpoint Blockade in Patients With Clinical Stage III or Oligometastatic Stage IV Melanoma
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving nivolumab alone or in
combination with ipilimumab before and after surgery can help to control metastatic
melanoma. The safety of these drugs will also be studied.